64Cu-FAPI-04

N/A

Report date: 2025/11/07 11:34:21

Base Information

Drug Name64Cu-FAPI-04
Drug Alias NameN/A
ClassificationRadiation-emitting products > Nuclides > Copper > 64CuRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates
Mechanisms of ActionFibroblast activation protein alpha binders
TargetsProlyl endopeptidase FAP
Therapy Area/IndicationsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermanyJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOsaka UniversityGerman Cancer Research Center (Dkfz)
China Registration ClassN/A

Develop Information

Active CompaniesGerman Cancer Research Center (Dkfz)Osaka University
Inactive CompaniesN/A
Active IndicationsPancreatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A